4.6 Review

Osteocalcin in the brain: from embryonic development to age-related decline in cognition

期刊

NATURE REVIEWS ENDOCRINOLOGY
卷 14, 期 3, 页码 174-182

出版社

NATURE PORTFOLIO
DOI: 10.1038/nrendo.2017.181

关键词

-

资金

  1. Columbia Aging Center
  2. Endocrinology Training Grant from the NIH [5T32DK007328-38]
  3. Fondation pour la Recherche Medicale grant [AJE20130928594]
  4. Human Frontier Scientific Program-Grant [ATIP-AVENIR INSERM - R14080KS - RSE15007KSA]
  5. Human Frontier Scientific Program-Grant AGEMED-INSERM
  6. Philippe Foundation
  7. [2P01 AG032959-06A1]

向作者/读者索取更多资源

A remarkable, unexpected aspect of the bone-derived hormone osteocalcin is that it is necessary for both brain development and brain function in the mouse, as its absence results in a profound deficit in spatial learning and memory and an exacerbation of anxiety-like behaviour. The regulation of cognitive function by osteocalcin, together with the fact that its circulating levels decrease in midlife compared with adolescence in all species tested, raised the prospect that osteocalcin might be an anti-geronic hormone that could prevent age-related cognitive decline. As presented in this Review, recent data indicate that this is indeed the case and that osteocalcin is necessary for the anti-geronic activity recently ascribed to the plasma of young wild-type mice. The diversity and amplitude of the functions of osteocalcin in the brain, during development and postnatally, had long called for the identification of its receptor in the brain, which was also recently achieved. This Review presents our current understanding of the biology of osteocalcin in the brain, highlighting the bony vertebrate specificity of the regulation of cognitive function and pointing toward where therapeutic opportunities might exist.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据